Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
The American Journal of Cardiology|February 13, 2007
Neurocardiogenic mechanisms of unexplained syncope in idiopathic dilated cardiomyopathyEfthimios G Livanis, Anna Kostopoulou, George N Theodorakis, et al.
Perfusion|September 6, 2024
Successful management of pulmonary hemorrhage from lung carcinoid, in a patient on VenoArterial extracorporeal membrane oxygenation supportAntigoni Koliopoulou, Michael Antonopoulos, Fotios Theodoropoulos, et al.
Acute Cardiac Care|October 3, 2006
Primary stenting of an unprotected left main coronary artery total occlusion in a patient with acute myocardial infraction and cardiogenic shockGeorge K Karavolias, Panagiota Georgiadou, Efstathios K Iliodromitis, et al.
International Journal of Cardiology|March 18, 2005
Levosimendan reduces plasma B-type natriuretic peptide and interleukin 6, and improves central hemodynamics in severe heart failure patientsStamos Kyrzopoulos, Stamatis Adamopoulos, John T Parissis, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|February 1, 2013
Automated knowledge-based fuzzy models generation for weaning of patients receiving ventricular assist device (VAD) therapyMarkos G Tsipouras, Evaggelos C Karvounis, Alexandros T Tzallas, et al.
BMC Medical Genetics|April 7, 2019
A case report of recessive restrictive cardiomyopathy caused by a novel mutation in cardiac troponin I (TNNI3)Malena P Pantou, Polyxeni Gourzi, Aggeliki Gkouziouta, et al.
European Journal of Medical Genetics|May 14, 2018
A new phenotype of severe dilated cardiomyopathy associated with a mutation in the LAMP2 gene previously known to cause hypertrophic cardiomyopathy in the context of Danon diseasePolyxeni Gourzi, Malena P Pantou, Angeliki Gkouziouta, et al.
The American Journal of Cardiology|August 2, 2005
Effects of levosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failureJohn T Parissis, Fotios Panou, Dimitrios Farmakis, et al.
Cytokine|February 2, 2011
Cytokine gene polymorphisms are associated with markers of disease severity and prognosis in patients with idiopathic dilated cardiomyopathyStamatis Adamopoulos, Fotis Kolokathis, Angeliki Gkouziouta, et al.
American Heart Journal|August 15, 2002
Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathyStamatis Adamopoulos, John T Parissis, Michael Georgiadis, et al.
Pageof 11